Impact of Exogenous Sequences on the Characteristics of an Epidemic Type 2 Recombinant Vaccine-Derived Poliovirus
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Pathogenic circulating vaccine-derived polioviruses (cVDPVs) have become a major obstacle to the successful completion of the global polio eradication program. Most cVDPVs are recombinant between the oral poliovirus vaccine (OPV) and human enterovirus species C (HEV-C). To study the role of HEV-C sequences in the phenotype of cVDPVs, we generated a series of recombinants between a Madagascar cVDPV isolate and its parental OPV type 2 strain. Results indicated that the HEV-C sequences present in this cVDPV contribute to its characteristics, including pathogenicity, suggesting that interspecific recombination contributes to the phenotypic biodiversity of polioviruses and may favor the emergence of cVDPVs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Results indicated that the other HEV-C sequences present in this cVDPV contribute to its characteristics, including pathogenicity, suggesting that PV/CAV recombination may favor the emergence of cVDPVs [113].”
From Recombination between Poliovirus and Coxsackie A Viruses of Species C: A Model of Viral Genetic Plasticity and Emergence (2011) · cites this paper as [113]
Citations
Cites
A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS12
REED, L. J., & MUENCH, H. (1938) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a118408 · Cited by 19,926
A simple method of estimating 50 per cent end points
Muench, H. (1938) · Medical Entomology and Zoology · Cited by 8,376
VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION
Kew, O. M., Sutter, R. W., de Gourville, E. M., Dowdle, W. R., & Pallansch, M. A. (2005) · Annual Review of Microbiology · doi:10.1146/annurev.micro.58.030603.123625 · Cited by 703
Kew, O., Morris-Glasgow, V., Landaverde, M., Burns, C., Shaw, J., Garib, Z., André, J., Blackman, E., Freeman, C. J., Jorba, J., et al. (2002) · Science · doi:10.1126/science.1068284 · Cited by 600
Synthesis of infectious poliovirus RNA by purified T7 RNA polymerase.
van der Werf, S., Bradley, J., Wimmer, E., Studier, F. W., & Dunn, J. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.8.2330 · Cited by 337
One hundred years of poliovirus pathogenesis
Racaniello, V. R. (2006) · Virology · doi:10.1016/j.virol.2005.09.015 · Cited by 322 · cited 1×
“The 5 UTR determinant, implicated in the temperature sensitivity of the strain, is thought to affect the structure of the internal ribosomal entry site, the translation of the viral genome, virus multiplication in certain tissues and cells, including in neuronal cells, and virus spread in the infected host (18, 25).”
BackgroundCirculating vaccine-derived polioviruses: current state of knowledge.
Kew, O. M., Wright, P. F., Agol, V. I., Delpeyroux, F., Shimizu, H., Nathanson, N., & Pallansch, M. A. (2004) · PubMed · doi:10.1590/s0042-96862004000100006 · Cited by 258
Self-citationSampling variation of the fifty percent end-point, determined by the Reed-Muench (Behrens) method.
Pizzi, M. (1950) · PubMed · Cited by 255
Brown, B., Oberste, M. S., Maher, K., & Pallansch, M. A. (2003) · Journal of Virology · doi:10.1128/jvi.77.16.8973-8984.2003 · Cited by 238
Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993
Yang, C.-F., Naguib, T., Yang, S.-J., Nasr, E., Jorba, J., Ahmed, N., Campagnoli, R., van der Avoort, H., Shimizu, H., Yoneyama, T., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.15.8366-8377.2003 · Cited by 233
The molecular biology of poliovaccines
Minor, P. D. (1992) · Journal of General Virology · doi:10.1099/0022-1317-73-12-3065 · Cited by 217
Rieder, E., Paul, A. V., Kim, D. W., van Boom, J. H., & Wimmer, E. (2000) · Journal of Virology · doi:10.1128/jvi.74.22.10371-10380.2000 · Cited by 167
Identification of two determinants that attenuate vaccine-related type 2 poliovirus
Ren, R. B., Moss, E. G., & Racaniello, V. R. (1991) · Journal of Virology · doi:10.1128/jvi.65.3.1377-1382.1991 · Cited by 163
Martín, J., Dunn, G., Hull, R., Patel, V., & Minor, P. D. (2000) · Journal of Virology · doi:10.1128/jvi.74.7.3001-3010.2000 · Cited by 160 · cited 1×
“However, reversion to neurovirulence of OPV strains has since been observed in both immunodeficient (20, 34) and healthy (21) individuals.”
BackgroundTemperature-sensitive mutants of enterovirus 71 show attenuation in cynomolgus monkeys
Arita, M., Shimizu, H., Nagata, N., Ami, Y., Suzaki, Y., Sata, T., Iwasaki, T., & Miyamura, T. (2005) · Journal of General Virology · doi:10.1099/vir.0.80784-0 · Cited by 156
Multiple Genetic Changes Can Occur in the Oral Poliovaccines upon Replication in Humans
Kew, O. M., Nottay, B. K., Hatch, M. H., Nakano, J. H., & Obijeski, J. F. (1981) · Journal of General Virology · doi:10.1099/0022-1317-56-2-337 · Cited by 148
Circulation of type 1 vaccine-derived poliovirus in the philippines in 2001
Shimizu, H., Thorley, B., Paladin, F. J., Brussen, K. A., Stambos, V., Yuen, L., Utama, A., Tano, Y., Arita, M., Yoshida, H., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.24.13512-13521.2004 · Cited by 146
Genetic basis of attenuation of the Sabin type-2 vaccine strain of poliovirus in primates.
Macadam, A. J., Pollard, S. R., Ferguson, G., Skuce, R., Wood, D., Almond, J. W., & Minor, P. D. (1993) · Virology · doi:10.1006/viro.1993.1003 · Cited by 139
Recombinant Vaccine–Derived Poliovirus in Madagascar
Rousset, D., Rakoto-Andrianarivelo, M., Razafindratsimandresy, R., Randriamanalina, B., Guillot, S., Balanant, J., Mauclère, P., & Delpeyroux, F. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0907.020692 · Cited by 138 · cited 1×
“children with poliomyelitis in Madagascar in 2002 (31).”
BackgroundSelf-citationLentz, K. N., Smith, A. D., Geisler, S. C., Cox, S., Buontempo, P. J., Skelton, A., DeMartino, J., Rozhon, E. J., Schwartz, J. L., GIRIJAVALLABHAN, V. M., et al. (1997) · Structure · doi:10.1016/s0969-2126(97)00249-9 · Cited by 123
Khetsuriani, N., Prevots, D. R., Quick, L., Elder, M. E., Pallansch, M., Kew, O., & Sutter, R. W. (2003) · The Journal of Infectious Diseases · doi:10.1086/379791 · Cited by 110
Shulman, L. M., Manor, Y., Handsher, R., Delpeyroux, F., McDonough, M. J., Halmut, T., Silberstein, I., Alfandari, J., Quay, J., Fisher, T., et al. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.10.3729-3734.2000 · Cited by 109
Self-citationJiang, P., Faase, J. A. J., Toyoda, H., Paul, A., Wimmer, E., & Gorbalenya, A. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700451104 · Cited by 105
Horie, H., Koike, S., Kurata, T., Sato-Yoshida, Y., Ise, I., Ota, Y., Abe, S., Hioki, K., Kato, H., & Taya, C. (1994) · Journal of Virology · doi:10.1128/jvi.68.2.681-688.1994 · Cited by 96
Co-Circulation and Evolution of Polioviruses and Species C Enteroviruses in a District of Madagascar
Rakoto-Andrianarivelo, M., Guillot, S., Iber, J., Balanant, J., Blondel, B., Riquet, F., Martin, J., Kew, O., Randriamanalina, B., Razafinimpiasa, L., et al. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030191 · Cited by 96 · cited 12×
“Genetic analyses of recombinant cVDPV strains and cocirculating enteroviruses have recently shown that HEV-C isolates (coxsackievirus strains A13 and A17) exhibit highest similarity with these cVDPVs in the genomic regions encoding the nonstructural proteins and in the 3 UTR (3, 26).”
BackgroundMethodSelf-citationArita, M., Zhu, S.-L., Yoshida, H., Yoneyama, T., Miyamura, T., & Shimizu, H. (2005) · Journal of Virology · doi:10.1128/jvi.79.20.12650-12657.2005 · Cited by 95 · cited 6×
“Genetic analyses of recombinant cVDPV strains and cocirculating enteroviruses have recently shown that HEV-C isolates (coxsackievirus strains A13 and A17) exhibit highest similarity with these cVDPVs in the genomic regions encoding the nonstructural proteins and in the 3 UTR (3, 26).”
BackgroundInfluentialAn Outbreak of Poliomyelitis Caused by Type 1 Vaccine‐Derived Poliovirus in China
Liang, X., Zhang, Y., Xu, W., Wen, N., Zuo, S., Lee, L. A., & Yu, J. (2006) · The Journal of Infectious Diseases · doi:10.1086/506359 · Cited by 87
Chevaliez, S., Szendrôi, A., Caro, V., Balanant, J., Guillot, S., Berencsi, G., & Delpeyroux, F. (2004) · Virology · doi:10.1016/j.virol.2004.04.026 · Cited by 81
Self-citationA Large Vaccine‐Derived Poliovirus Outbreak on Madura Island—Indonesia, 2005
Estívariz, C. F., Watkins, M. A., Handoko, D., Rusipah, R., Deshpande, J., Rana, B. J., Irawan, E., Widhiastuti, D., Pallansch, M. A., Thapa, A., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/525049 · Cited by 77
Molecular Mechanisms of Poliovirus Variation and Evolution
Agol, V. I. (2006) · Current Topics in Microbiology and Immunology · doi:10.1007/3-540-26397-7_8 · Cited by 73
Macadam, A. J., Ferguson, G., Burlison, J., Stone, D., Skuce, R., Almond, J. W., & Minor, P. D. (1992) · Virology · doi:10.1016/0042-6822(92)90565-7 · Cited by 71 · cited 1×
“The 5 UTR determinant, implicated in the temperature sensitivity of the strain, is thought to affect the structure of the internal ribosomal entry site, the translation of the viral genome, virus multiplication in certain tissues and cells, including in neuronal cells, and virus spread in the infected host (18, 25).”
BackgroundA mutation in the RNA polymerase of poliovirus type 1 contributes to attenuation in mice
Tardy-Panit, M., Blondel, B., Martin, A., Tekaia, F., Horaud, F., & Delpeyroux, F. (1993) · Journal of Virology · doi:10.1128/jvi.67.8.4630-4638.1993 · Cited by 64
Self-citationLong-Term Excretion of Vaccine-Derived Poliovirus by a Healthy Child
Martín, J., Odoom, K., Tuite, G., Dunn, G., Hopewell, N., Cooper, G., Fitzharris, C., Butler, K., Hall, W. W., & Minor, P. D. (2004) · Journal of Virology · doi:10.1128/jvi.78.24.13839-13847.2004 · Cited by 64
Cherkasova, E. A., Yakovenko, M. L., Rezapkin, G. V., Korotkova, E. A., Ivanova, O. E., Eremeeva, T. P., Krasnoproshina, L. I., Romanenkova, N. I., Rozaeva, N. R., Sirota, L., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.2.1062-1070.2005 · Cited by 55 · cited 1×
“In fact, both attenuation determinants mentioned above were mutated in the neurovirulent cMAD04, cMAD04/S2, and cMAD042A/S2 viruses (nt 481 A3G and aa 143 Ile3Thr, respectively) as well as in previously described pathogenic Sabin2 mutants (5, 7, 19, 26, 28).”
BackgroundBiological Significance of a Human Enterovirus B-Specific RNA Element in the 3′ Nontranslated Region
Merkle, I., van Ooij, M. J. M., van Kuppeveld, F. J. M., Glaudemans, D. H. R. F., Galama, J. M. D., Henke, A., Zell, R., & Melchers, W. J. G. (2002) · Journal of Virology · doi:10.1128/jvi.76.19.9900-9909.2002 · Cited by 45
Mutations in Sabin 2 Strain of Poliovirus and Stability of Attenuation Phenotype
Rezapkin, G. V., Fan, L., Asher, D. M., Fibi, M. R., Dragunsky, E. M., & Chumakov, K. M. (1999) · Virology · doi:10.1006/viro.1999.9718 · Cited by 40
Equestre, M., Genovese, D., Cavalieri, F., Fiore, L., Santoro, R., & Bercoff, R. P. (1991) · Journal of Virology · doi:10.1128/jvi.65.5.2707-2710.1991 · Cited by 27
Georgescu, M. M., Tardy-Panit, M., Guillot, S., Crainic, R., & Delpeyroux, F. (1995) · Journal of Virology · doi:10.1128/jvi.69.9.5278-5286.1995 · Cited by 26
Self-citationGlobal update on vaccine-derived polioviruses, January 2006-August 2007.
(2007) · PubMed · Cited by 14
Vaccine-derived polioviruses--update.
(2006) · PubMed · Cited by 8
Research works printed but not linked: 2
- Reed, L. J., and M. Muench. 1938. A simple method for estimating fifty percent endpoints. Am. J. Hyg.27:493-497.
- Sutter, R. W., and R. Prevots. 1994. Vaccine-associated paralytic poliomyelitis among immunodeficient persons. Infect. Med.11:426-438.
Cited by
Combelas, N., Holmblat, B., Joffret, M.-L., Colbère-Garapin, F., & Delpeyroux, F. (2011) · Viruses · doi:10.3390/v3081460 · Cited by 135
Self-citationRecombination in Enteroviruses, a Multi-Step Modular Evolutionary Process
Muslin, C., Kain, A. M., Bessaud, M., Blondel, B., & Delpeyroux, F. (2019) · Viruses · doi:10.3390/v11090859 · Cited by 142
Self-citationJegouic, S., Joffret, M.-L., Blanchard, C., Riquet, F. B., Perret, C., Pelletier, I., Colbere-Garapin, F., Rakoto-Andrianarivelo, M., & Delpeyroux, F. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000412 · Cited by 116
Self-citationRecombination among human non-polio enteroviruses: implications for epidemiology and evolution
Kyriakopoulou, Z., Pliaka, V., Amoutzias, G. D., & Markoulatos, P. (2014) · Virus Genes · doi:10.1007/s11262-014-1152-y · Cited by 96
Lauber, C., & Gorbalenya, A. E. (2012) · Journal of Virology · doi:10.1128/jvi.07173-11 · Cited by 100
Metadata
- Authors
- Riquet, F. B., Blanchard, C., Jegouic, S., Balanant, J., Guillot, S., Vibet, M.-A., Rakoto-Andrianarivelo, M., & Delpeyroux, F.
- Affiliations
- Unité de Biologie des Virus Entériques
- Institut Pasteur (FR)
- Unité de Virologie Médicale, Institut Pasteur de Madagascar, Antananarivo, Madagascar
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2008-09
- Volume
- 82
- Issue
- 17
- Pages
- 8927-8932
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- PMC
- PMC2519664
- OpenAlex
- W1969202007
- Cited by
- 29
- References
- 40
- Citations by year
- 2024: 1 · 2023: 1 · 2022: 1 · 2020: 1 · 2019: 2 · 2018: 2 · 2017: 2 · 2016: 1 · 2015: 2 · 2014: 3 · 2013: 2 · 2012: 7
- FWCI
- 0.97
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Virology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Keywords
- circulating vaccine-derived poliovirus, poliovirus type 2, interspecific recombination, oral polio vaccine, pathogenicity, polio eradication, phenotypic diversity
- MeSH terms
- Base Sequence, Disease Outbreaks, Humans, Kinetics, Molecular Sequence Data, Poliomyelitis, Poliovirus Vaccine, Oral, Recombination, Genetic, Vaccines, Synthetic, Virus Replication, Poliovirus, DNA, Complementary, Enterovirus C, Human, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.